TAR syndrome: Clinical and molecular characterization of a cohort of 26 patients and description of novel noncoding variants of RBM8A.


Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
07 2020
Historique:
received: 13 11 2019
revised: 18 02 2020
accepted: 22 03 2020
pubmed: 1 4 2020
medline: 6 11 2021
entrez: 1 4 2020
Statut: ppublish

Résumé

Thrombocytopenia-absent radius (TAR) syndrome is characterized by radial defect and neonatal thrombocytopenia. It is caused by biallelic variants of RBM8A gene (1q21.1) with the association of a null allele and a hypomorphic noncoding variant. RBM8A encodes Y14, a core protein of the exon junction complex involved in messenger RNA maturation. To date, only two hypomorphic variants have been identified. We report on a cohort of 26 patients affected with TAR syndrome and carrying biallelic variants in RBM8A. Half patients carried a 1q21.1 deletion and one of the two known hypomorphic variants. Four novel noncoding variants of RBM8A were identified in the remaining patients. We developed experimental models enabling their functional characterization in vitro. Two variants, located respectively in the 5'-untranslated region (5'-UTR) and 3'-UTR regions, are responsible for a diminished expression whereas two intronic variants alter splicing. Our results bring new insights into the molecular knowledge of TAR syndrome and enabled us to propose genetic counseling for patients' families.

Identifiants

pubmed: 32227665
doi: 10.1002/humu.24021
doi:

Substances chimiques

5' Untranslated Regions 0
RBM8A protein, human 0
RNA-Binding Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1220-1225

Informations de copyright

© 2020 Wiley Periodicals, Inc.

Références

Albers, C. A., Newbury-Ecob, R., Ouwehand, W. H., & Ghevaert, C. (2013). New insights into the genetic basis of TAR (thrombocytopenia-absent radii) syndrome. Current Opinion in Genetics & Development, 23(3), 316-323. https://doi.org/10.1016/j.gde.2013.02.015
Albers, C. A., Paul, D. S., Schulze, H., Freson, K., Stephens, J. C., Smethurst, P. A., … Ghevaert, C. (2012). Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome. Nature Genetics, 44(4), 435-439. https://doi.org/10.1038/ng.1083
Blazquez, L., Emmett, W., Faraway, R., Pineda, J. M. B., Bajew, S., Gohr, A., … Ule, J. (2018). Exon Junction complex shapes the transcriptome by repressing recursive splicing. Molecular Cell, 72(3), 496-509.e9. https://doi.org/10.1016/j.molcel.2018.09.033
Bottillo, I., Castori, M., De Bernardo, C., Fabbri, R., Grammatico, B., Preziosi, N., … Grammatico, P. (2013). Prenatal diagnosis and postmortem examination in a fetus with thrombocytopenia-absent radius (TAR) syndrome due to compound heterozygosity for a 1q21.1 microdeletion and a RBM8A hypomorphic allele: A case report. BMC Research Notes, 6, 376. https://doi.org/10.1186/1756-0500-6-376
Chamieh, H., Ballut, L., Bonneau, F., & Le Hir, H. (2008). NMD factors UPF2 and UPF3 bridge UPF1 to the exon junction complex and stimulate its RNA helicase activity. Nature structural & molecular biology, 15(1), 85-93. https://doi.org/10.1038/nsmb1330
Fleischman, R. A., Letestu, R., Mi, X., Stevens, D., Winters, J., Debili, N., & Vainchenker, W. (2002). Absence of mutations in the HoxA10, HoxA11, and HoxD11 nucleotide coding sequences in thrombocytopenia with absent radius syndrome. British Journal of Haematology, 116(2), 367-375.
Gehring, N. H., Neu-Yilik, G., Schell, T., Hentze, M. W., & Kulozik, A. E. (2003). Y14 and hUpf3b form an NMD-activating complex. Molecular Cell, 11(4), 939-949.
Giordano, P., Cecinati, V., Grassi, M., Giordani, L., Mattia, D. D., & Santoro, N. (2011). Langerhans cell histiocytosis in a pediatric patient with thrombocytopenia-absent radius syndrome and 1q21.1 deletion: Case report and proposal of a rapid molecular diagnosis of 1q21.1 deletion. Immunopharmacology and Immunotoxicology, 33(4), 754-758. https://doi.org/10.3109/08923973.2011.557077
Greenhalgh, K., Howell, R., Bottani, A., Ancliff, P., Brunner, H., Verschuuren-Bemel, C., … Newbury-Ecob, R. (2002). Thrombocytopenia-absent radius syndrome: A clinical genetic study. Journal of Medical Genetics, 39(12), 876-881. https://doi.org/10.1136/jmg.39.12.876
Gross, H., Groh, C., & Weippl, G. (1956). Congenital hypoplastic thrombopenia with aplasia of the radius, a syndrome of multiple variations. Neue Osterreichische Zeitschrift fur Kinderheilkunde, 1(4), 574-582.
Hachet, O., & Ephrussi, A. (2001). Drosophila Y14 shuttles to the posterior of the oocyte and is required for oskar mRNA transport. Current Biology, 11(21), 1666-1674. https://doi.org/10.1016/S0960-9822(01)00508-5
Hall, J. G. (1987). Thrombocytopenia and absent radius (TAR) syndrome. Journal of Medical Genetics, 24(2), 79-83.
Hall, J. G., Levin, J., Kuhn, J. P., Ottenheimer, E. J., van Berkum, K. A., & McKusick, V. A. (1969). Thrombocytopenia with absent radius (TAR). Medicine, 48(6), 411-439.
Hedberg, V. A., & Lipton, J. M. (1988). Thrombocytopenia with absent radii. A review of 100 cases. The American Journal of Pediatric Hematology/Oncology, 10(1), 51-64.
Hipólito, L. N., Mendoza-Cembranos, M. D., Villaescusa, M. T., Jo-Velasco, M., Requena, L., & Alegría-Landa, V. (2019). Langerhans cell histiocytosis and multiple reticulohistiocytomas in a patient with TAR syndrome: An association not previously described. Journal of Cutaneous Pathology, 46(8), 609-612. https://doi.org/10.1111/cup.13483
Hir, H. L., Izaurralde, E., Maquat, L. E., & Moore, M. J. (2000). The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions. The EMBO Journal, 19(24), 6860-6869. https://doi.org/10.1093/emboj/19.24.6860
Houeijeh, A., Andrieux, J., Saugier-Veber, P., David, A., Goldenberg, A., Bonneau, D., … Manouvrier-Hanu, S. (2011). Thrombocytopenia-absent radius (TAR) syndrome: A clinical genetic series of 14 further cases. Impact of the associated 1q21.1 deletion on the genetic counselling. European Journal of Medical Genetics, 54(5), e471-e477. https://doi.org/10.1016/j.ejmg.2011.05.001
Jourdain, A. S., Petit, F., Odou, M. F., Balduyck, M., Brunelle, P., Dufour, W., … Escande, F. (2020). Multiplex targeted high-throughput sequencing in a series of 352 patients with congenital limb malformations. Human Mutation, 41, 222-239. https://doi.org/10.1002/humu.23912
Kataoka, N., Diem, M. D., Kim, V. N., Yong, J., & Dreyfuss, G. (2001). Magoh, a human homolog of Drosophila mago nashi protein, is a component of the splicing-dependent exon-exon junction complex. The EMBO Journal, 20(22), 6424-6433. https://doi.org/10.1093/emboj/20.22.6424
Kataoka, N., Diem, M. D., Yoshida, M., Hatai, C., Dobashi, I., Dreyfuss, G., … Ohno, M. (2011). Specific Y14 domains mediate its nucleo-cytoplasmic shuttling and association with spliced mRNA. Scientific Reports, 1(1), 92. https://doi.org/10.1038/srep00092
Klopocki, E., Schulze, H., Strauß, G., Ott, C.-E., Hall, J., Trotier, F., … Mundlos, S. (2007). Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome. The American Journal of Human Genetics, 80(2), 232-240. https://doi.org/10.1086/510919
Le Hir, H., Gatfield, D., Izaurralde, E., & Moore, M. J. (2001). The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. The EMBO Journal, 20(17), 4987-4997. https://doi.org/10.1093/emboj/20.17.4987
Le Hir, H., & Séraphin, B. (2008). EJCs at the heart of translational control. Cell, 133(2), 213-216. https://doi.org/10.1016/j.cell.2008.04.002
Nicchia, E., Giordano, P., Greco, C., Rocco, D. D., & Savoia, A. (2016). Molecular diagnosis of thrombocytopenia-absent radius syndrome using next-generation sequencing. International Journal of Laboratory Hematology, 38(4), 412-418. https://doi.org/10.1111/ijlh.12516
Palacios, I. M., Gatfield, D., St Johnston, D., & Izaurralde, E. (2004). An eIF4AIII-containing complex required for mRNA localization and nonsense-mediated mRNA decay. Nature, 427(6976), 753-757. https://doi.org/10.1038/nature02351
Papoulidis, I., Oikonomidou, E., Orru, S., Siomou, E., Kontodiou, M., Eleftheriades, M., … Manolakos, E. (2014). Prenatal detection of TAR syndrome in a fetus with compound inheritance of an RBM8A SNP and a 334-kb deletion: A case report. Molecular Medicine Reports, 9(1), 163-165. https://doi.org/10.3892/mmr.2013.1788
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., & Rehm, H. L. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 17(5), 405-424. https://doi.org/10.1038/gim.2015.30
Schnur, R. E., Eunpu, D. L., & Zackai, E. H. (1987). Thrombocytopenia with absent radius in a boy and his uncle. American Journal of Medical Genetics, 28(1), 117-123. https://doi.org/10.1002/ajmg.1320280117
Shaw, S., & Oliver, R. A. (1959). Congenital hypoplastic thrombocytopenia with skeletal deformaties in siblings. Blood, 14(4), 374-377.
Shibuya, T., Tange, T. Ø., Sonenberg, N., & Moore, M. J. (2004). eIF4AIII binds spliced mRNA in the exon junction complex and is essential for nonsense-mediated decay. Nature Structural & Molecular Biology, 11(4), 346-351. https://doi.org/10.1038/nsmb750
Strippoli, P., Savoia, A., Iolascon, A., Tonelli, R., Savino, M., Giordano, P., … Bagnara, G. P. (1998). Mutational screening of thrombopoietin receptor gene (c-mpl) in patients with congenital thrombocytopenia and absent radii (TAR). British Journal of Haematology, 103(2), 311-314.
Wang, Z., Ballut, L., Barbosa, I., & Le Hir, H. (2018). Exon junction complexes can have distinct functional flavours to regulate specific splicing events. Scientific Reports, 8(1), 9509. https://doi.org/10.1038/s41598-018-27826-y
Ward, R. E., Bixler, D., Provisor, A. J., & Bader, P. (1986). Parent to child transmission of the thrombocytopenia absent radius (TAR) syndrome. American Journal of Medical Genetics Supplement, 2, 207-214.
Wiegand, H. L., Lu, S., & Cullen, B. R. (2003). Exon junction complexes mediate the enhancing effect of splicing on mRNA expression. Proceedings of the National Academy of Sciences, 100(20), 11327-11332. https://doi.org/10.1073/pnas.1934877100
Yassaee, V. R., Hashemi-Gorji, F., Soltani, Z., & Poorhosseini, S. M. (2014). A new approach for molecular diagnosis of TAR syndrome. Clinical Biochemistry, 47(9), 835-839. https://doi.org/10.1016/j.clinbiochem.2014.04.018

Auteurs

Simon Boussion (S)

Clinical Genetics Department, Reference Center for Developmental Anomalies, CHU Lille, Lille, France.
EA7364-RADEME, Lille University, Lille, France.

Fabienne Escande (F)

EA7364-RADEME, Lille University, Lille, France.
Biochemistry and Molecular Oncology Laboratory, CHU Lille, Lille, France.

Anne-Sophie Jourdain (AS)

EA7364-RADEME, Lille University, Lille, France.
Biochemistry and Molecular Oncology Laboratory, CHU Lille, Lille, France.

Thomas Smol (T)

EA7364-RADEME, Lille University, Lille, France.
Medical Genetics Department, CHU Lille, Lille, France.

Perrine Brunelle (P)

EA7364-RADEME, Lille University, Lille, France.
Biochemistry and Molecular Oncology Laboratory, CHU Lille, Lille, France.

Céline Duhamel (C)

EA7364-RADEME, Lille University, Lille, France.

Yves Alembik (Y)

Medical Genetics Department, CHU Strasbourg, Strasbourg, France.

Tania Attié-Bitach (T)

Histology, Embryology and Cytogenetics Department, Necker-Enfants Malades Hospital, AP-HP, Paris, France.

Geneviève Baujat (G)

Clinical Genetics Department, Necker-Enfants Malades Hospital, AP-HP, INSERM UMR, IMAGINE Institute, Paris, France.

Anne Bazin (A)

Antenatal Diagnosis Department, René Dubois Hospital, Pontoise, France.

Maryse Bonnière (M)

Histology, Embryology and Cytogenetics Department, Necker-Enfants Malades Hospital, AP-HP, Paris, France.

Philippe Carassou (P)

Hematology Department, CHR Metz-Thionville, Metz, France.

Dominique Carles (D)

Anatomo-Pathology Department, CHU Bordeaux, Bordeaux, France.

Louise Devisme (L)

EA7364-RADEME, Lille University, Lille, France.
Anatomo-Pathology Institute, CHU Lille, Lille, France.

Cyril Goizet (C)

Medical Genetics Department, CHU Bordeaux, MRGM Laboratory, INSERM, Bordeaux University, Bordeaux, France.

Alice Goldenberg (A)

Genetics Department, Reference Center for Developmental Anomalies, CHU Rouen, Rouen, France.

Sarah Grotto (S)

Genetics Department, Robert Debré Hospital, AP-HP, Paris, France.

Agnès Guichet (A)

Genetics Department, CHU Angers, Angers, France.

Pierre-Simon Jouk (PS)

Genetics Department, CHU Grenoble-Alpes, Grenoble, France.

Laurence Loeuillet (L)

Anatomo-Cytopathology Department, Cochin Hospital, AP-HP, Paris, France.

Charlotte Mechler (C)

Foetopathology Department, Robert Debré Hospital, AP-HP, Paris, France.

Caroline Michot (C)

Clinical Genetics Department, Necker-Enfants Malades Hospital, AP-HP, INSERM UMR, IMAGINE Institute, Paris, France.

Fanny Pelluard (F)

INSERM U1053-UMR BaRITOn, Foetopathology Department, Pellegrin Hospital, CHU Bordeaux, Bordeaux, France.

Audrey Putoux (A)

Genetics Department, Hospices Civils de Lyon, Lyon, France.
GENDEV Team, CRNL, INSERM U1028, CNRS UMR 5292, UCBL1, Lyon, France.

Sandra Whalen (S)

Clinical Genetics, Reference Center for Developmental Anomalies, Armand Trousseau Hospital, AP-HP, Paris, France.

Jamal Ghoumid (J)

Clinical Genetics Department, Reference Center for Developmental Anomalies, CHU Lille, Lille, France.
EA7364-RADEME, Lille University, Lille, France.

Sylvie Manouvrier-Hanu (S)

Clinical Genetics Department, Reference Center for Developmental Anomalies, CHU Lille, Lille, France.
EA7364-RADEME, Lille University, Lille, France.

Florence Petit (F)

Clinical Genetics Department, Reference Center for Developmental Anomalies, CHU Lille, Lille, France.
EA7364-RADEME, Lille University, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH